Clinical Benefit of CBT for Insomnia in Primary Care

This study has been completed.
Sponsor:
Information provided by:
NHS Greater Clyde and Glasgow
ClinicalTrials.gov Identifier:
NCT00170417
First received: September 9, 2005
Last updated: NA
Last verified: December 2000
History: No changes posted
  Purpose

The purpose of this study is to evaluate using an RCT the potential benefits of CBT for insomnia in the community


Condition Intervention
Insomnia
Behavioral: Cognitive Behaviour Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Clinical and Health Economic Benefit of Non-Pharmacological Treatment of Chronic Insomnia in Primary Care

Further study details as provided by NHS Greater Clyde and Glasgow:

Study Start Date: December 2000
Estimated Study Completion Date: May 2003
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Adult years (18+), living at home
  • Meets clinical/RDC criteria for chronic insomnia

Exclusion Criteria:

  • Deteriorating health
  • Untreated major mental disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00170417

Locations
United Kingdom
Primary Care NHS
Glasgow and Edinburgh, United Kingdom
Sponsors and Collaborators
NHS Greater Clyde and Glasgow
Investigators
Principal Investigator: Colin A Espie, PhD University of Glasgow
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00170417     History of Changes
Other Study ID Numbers: CZH/4/Z
Study First Received: September 9, 2005
Last Updated: September 9, 2005
Health Authority: United Kingdom: National Health Service

ClinicalTrials.gov processed this record on September 16, 2014